World's Best Scientists 2026 revealed!
Cancer Genetics
H-index 13

Cancer Genetics

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Genetics 117 56 137 6
Biology and Biochemistry 629 73 174 8
Medicine 2138 137 178 11

Additional Metrics

Number of Best Scientists*: 272
Documents by Best Scientists*: 333
Top 100 Ranked Scientists*: 10
SCIMAGO H-index: 55
SCIMAGO SJR: 0.709
Impact Factor: 2.1

Overview

Top Research Topics at Cancer Genetics and Cytogenetics?

Cancer Genetics and Cytogenetics focuses on Genetics, Cancer research, Karyotype, Cytogenetics and Molecular biology. Chromosome, Gene, Breakpoint, Comparative genomic hybridization and Gene duplication are some of the study areas of Genetics discussed. The journal addresses concerns in Cancer research which are intertwined with other disciplines, such as Carcinogenesis, Cancer and Loss of heterozygosity.

While Cancer Genetics and Cytogenetics focused on Karyotype, it was also able to explore topics like Chromosome 7 (human) and Chromosomal translocation. More specifically, the research on Chromosomal translocation in Cancer Genetics and Cytogenetics is related to Philadelphia chromosome. In addition to Cytogenetics research, Cancer Genetics and Cytogenetics aims to explore topics under Aneuploidy, Trisomy, Immunology, Pathology and Monosomy.

The study of Internal medicine and how it intertwines with concepts under Endocrinology and Gastroenterology were explored in the presented Immunology research. The in-depth study on Pathology also explores topics in the intersecting field of Anatomy. In it, Fluorescence in situ hybridization, Gene rearrangement, Cell culture and In situ hybridization are investigated in conjunction with one another to address concerns in Molecular biology research.

  • Genetics (30.62%)
  • Cancer research (27.69%)
  • Karyotype (25.17%)

What are the most cited papers published in the journal?

  • Genetics of adult glioma (531 citations)
  • Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases and remarkable consistency of t(11;22)(q24;q12) (393 citations)
  • Cytogenetic findings in 200 patients with multiple myeloma. (336 citations)

Research areas of the most cited articles at Cancer Genetics and Cytogenetics:

The journal papers are mainly concerned with subjects like Genetics, Cytogenetics, Karyotype, Chromosome and Pathology. The works on Genetics tackled in the journal papers bring together disciplines like Molecular biology and Cancer research. Aside from discussions in Cytogenetics, the journal papers also deal with the subject of Immunology which intersects with Internal medicine disciplines.

What topics the last edition of the journal is best known for?

  • Cancer
  • Gene
  • Internal medicine

The previous edition focused in particular on these issues:

The journal mainly deals with areas of study such as Cancer research, Gene, Genetics, Computational biology and Internal medicine. The research on Cancer research tackled can also make contributions to studies in the areas of Cancer, Adenocarcinoma, Lung cancer and Exon. The majority of Genetics studies in the journal are focused on the subject of Microarray.

The journal tackles studies in Exome sequencing and the interrelated subject of Pathology to gain insights into Germline. The research on Myeloid leukemia featured in the journal combines topics in other fields like Fusion gene and Chromosomal translocation. The Chromosomal translocation study featured in the journal draws parallels with the field of Molecular biology.

The most cited articles from the last journal are:

  • DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy. (9 citations)
  • Consensus molecular subtyping of colorectal cancers is influenced by goblet cell content. (2 citations)
  • Promoter hypermethylation regulates vitamin D receptor (VDR) expression in colorectal cancer-A study from Kashmir valley. (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Cancer Genetics and Cytogenetics (based on the number of publications) are:

  • Avery A. Sandberg (290 papers) absent at the last edition,
  • Sverre Heim (166 papers) absent at the last edition,
  • Felix Mitelman (165 papers) absent at the last edition,
  • Nils Mandahl (134 papers) absent at the last edition,
  • Herman Van den Berghe (114 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Cancer Genetics and Cytogenetics (based on the number of publications) are:

  • Boston Children's Hospital (196 papers) published 2 papers at the last edition, 3 less than at the previous edition,
  • Roswell Park Cancer Institute (191 papers) absent at the last edition,
  • Lund University (190 papers) absent at the last edition,
  • Katholieke Universiteit Leuven (151 papers) absent at the last edition,
  • University of Texas MD Anderson Cancer Center (133 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 47.45% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 11.11% were posted by at least one author from the top 10 institutions publishing in the journal. Another 5.56% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 11.11% of all publications and 72.22% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Cancer treatments: Past, present, and future

    (2024)
    51 Citations
  • DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy.

    Larissa Costa de Almeida;Felipe Antunes Calil;João Agostinho Machado-Neto;Leticia Veras Costa-Lotufo

    (2021)
    49 Citations
  • The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time?

    Alexander Höllein;Sven O. Twardziok;Wencke Walter;Stephan Hutter

    (2020)
    38 Citations
  • A melanoma patient with macrophage-cancer cell hybrids in the primary tumor, a lymph node metastasis and a brain metastasis

    Greggory LaBerge;Eric Duvall;Zachary Grasmick;Kay Haedicke

    (2021)
    25 Citations
  • TRK inhibitor activity and resistance in TRK fusion-positive cancers in adults

    (2022)
    22 Citations
  • Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).

    Lisa J. McReynolds;Kajal Biswas;Neelam Giri;Shyam K. Sharan

    (2021)
    20 Citations
  • Genomic and transcriptomic features of dermatofibrosarcoma protuberans: Unusual chromosomal origin of the COL1A1-PDGFB fusion gene and synergistic effects of amplified regions in tumor development

    Jan Köster;Elsa Arbajian;Björn Viklund;Anders Isaksson

    (2020)
    18 Citations
  • Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemia.

    Calogero Vetro;Torsten Haferlach;Manja Meggendorfer;Anna Stengel

    (2020)
    18 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond traditional medical degrees, there are several online educational paths that complement a career in medicine. An online nutritionist degree offers a flexible way to specialize in diet and wellness, supporting holistic patient care.

Nurses looking to advance their qualifications can explore the cheapest rn to bsn online programs. These affordable options provide registered nurses with bachelor's degrees without interrupting their work schedules.

For healthcare professionals aiming to move into leadership roles, pursuing the fastest online mha can accelerate their path to management positions. These programs focus on healthcare administration and strategy, blending clinical knowledge with business skills.

Mental health practitioners can benefit from the shortest pmhnp program, which provides a fast track to becoming a Psychiatric Mental Health Nurse Practitioner. This specialization is critical to meeting the growing demand for mental health services.

Each of these online degrees supports diverse career pathways in the medical field, offering flexibility, affordability, and focused training to enhance professional growth.

Best Scientists Contributing to This Journal